Welcome to our dedicated page for Enovix Corporation SEC filings (Ticker: ENVXW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The ENVXW SEC filings page focuses on regulatory documents related to the Enovix Corporation warrants that traded under the ENVXW symbol. These filings help explain how the warrant program was structured, how it evolved over time, and how the ENVXW class was ultimately removed from listing on the Nasdaq Stock Market.
Key filings include multiple Form 8-K reports in which Enovix describes material events affecting the warrants. These 8-Ks summarize press releases announcing the distribution of the warrants as a dividend, the satisfaction of early expiration price conditions tied to the volume-weighted average price of Enovix common stock, the election of an alternate expiration date, and the mechanics by which warrants had to be exercised before they became void. The filings also reference a Notice of Guaranteed Delivery that outlined procedures for warrant holders whose financial institutions could not complete exercises before the deadline.
A central document for ENVXW is the Form 25 filed with the SEC, in which Nasdaq notified the Commission of the removal of the Enovix warrant class from listing and registration under Section 12(b) of the Exchange Act. This filing confirms that the ENVXW warrants, described simply as “Warrant” in the form, were struck from the exchange following the conclusion of the program.
Through Stock Titan, users can access these filings as they appear on EDGAR, while AI-powered tools can assist in interpreting the implications. For ENVXW, that means quickly understanding the timeline from warrant issuance to expiration, the conditions that triggered early expiration, and the formal delisting process. Users interested in Enovix more broadly can also look to related filings under ENVX for annual reports on Form 10-K, quarterly reports on Form 10-Q, and additional 8-Ks that discuss financial results, capital markets transactions and governance changes.
In addition, investors researching historical capital structure or derivative securities can use the ENVXW filings to see how the warrant terms were documented in the warrant agreement, how the company communicated with holders, and how proceeds from exercises were reported in subsequent disclosures. AI summaries can highlight the sections that address warrant exercise prices, expiration conditions, and the impact on Enovix’s equity.
Truong Kristina reported acquisition or exercise transactions in this Form 4 filing.
Enovix Corp Chief Accounting Officer Kristina Truong received a grant of 99,601 shares of common stock in the form of restricted stock units at no cash cost. These RSUs will vest in 12 equal quarterly installments starting on April 1, 2026, conditioned on her continued service.
Following this award, she holds 315,099 shares and rights, including 229,040 RSUs and vested performance RSUs scheduled for release in March 2027, April 2027, and April 2028. This filing reflects compensation rather than open‑market trading.
Chakravarthy Arthi reported acquisition or exercise transactions in this Form 4 filing.
Enovix Corp Chief Legal Officer Arthi Chakravarthy received an equity award of 159,362 shares of common stock in the form of restricted stock units (RSUs). The RSUs were granted at no cash cost and will vest in 12 equal quarterly installments starting from April 1, 2026, conditioned on continued service.
After this grant, Chakravarthy is reported as holding 611,007 shares of Enovix common stock, including 409,461 shares issuable upon vesting and settlement of RSUs, 10,393 vested performance RSUs scheduled for release in March 2027, and 58,500 additional performance RSUs scheduled for releases in April 2027 and April 2028.
Benton Ryan A reported acquisition or exercise transactions in this Form 4 filing.
Enovix Corp Chief Financial Officer Ryan A. Benton received a stock-based compensation award of 249,003 shares of common stock on April 1, 2026, in the form of restricted stock units (RSUs). The award was granted at no cash cost per share and is structured to vest in 12 equal quarterly installments starting from April 1, 2026, as long as he remains in continuous service through each vesting date.
Following this grant, Benton holds 1,002,693 shares of Enovix common stock, which includes 997,755 shares issuable upon future vesting and settlement of previously granted RSUs. This filing reflects a compensation-related equity grant rather than an open-market purchase or sale.
Talluri Rajendra K reported acquisition or exercise transactions in this Form 4 filing.
Enovix Corp President and CEO Rajendra K. Talluri received an equity award of 697,211 shares of common stock in the form of restricted stock units (RSUs) at no cash cost per share. The RSUs will vest in 12 equal quarterly installments starting from April 1, 2026, conditioned on his continued service.
After this grant, Talluri directly holds or has rights to 3,115,756 shares, including 2,106,647 shares issuable upon RSU vesting and settlement, 47,775 vested performance RSUs to be released in March 2027, and 259,611 additional performance RSUs scheduled for release in April 2027 and April 2028.
Enovix Corp Chief Accounting Officer Kristina Truong reported routine share withholdings for taxes tied to equity compensation, not open-market trades. On April 1 and April 5, a total of 2,858 shares of common stock were withheld to cover tax obligations associated with vesting restricted stock units.
After these tax-withholding dispositions, Truong held 215,498 shares of Enovix common stock directly. This figure includes 129,439–130,643 shares issuable upon future vesting and settlement of RSUs, as well as vested performance restricted stock units scheduled for release in March and April 2027–2028.
Enovix Corp Chief Legal Officer Arthi Chakravarthy had 3,337 shares of common stock withheld at $4.97 per share to cover tax obligations. This was tied to the vesting of restricted stock units and was not an open-market sale. After the tax withholding, Chakravarthy directly holds 451,645 shares, including 250,099 shares issuable upon RSU vesting and settlement and multiple tranches of performance restricted stock units scheduled for release in 2027 and 2028.
Enovix Corp President and CEO Rajendra K. Talluri reported a tax-related share disposition. On April 1, 2026, 15,569 shares of Enovix common stock were withheld at $4.97 per share to satisfy tax withholding obligations tied to the vesting of restricted stock units (RSUs).
After this withholding, Talluri holds 2,418,545 shares directly, including 1,409,436 shares issuable upon RSU vesting and settlement, 47,775 vested performance RSUs scheduled for release in March 2027, and 259,611 performance RSUs scheduled for release in April 2027 and April 2028.
Enovix Corp Chief Legal Officer Arthi Chakravarthy reported a routine tax-withholding share disposition related to equity compensation. On this Form 4, 2,221 shares of common stock were withheld at $4.88 per share to cover tax obligations from the vesting of restricted stock units.
After this withholding, Chakravarthy directly holds 454,982 shares of Enovix common stock. This total includes 256,400 shares issuable upon vesting and settlement of RSUs, 10,393 vested performance RSUs scheduled for release in March 2027, and 58,500 additional performance RSUs scheduled for release in April 2027 and April 2028.
Enovix Corp ownership filing shows The Vanguard Group reports 0 shares and 0% beneficial ownership of Common Stock in an Amendment No. 2 to a Schedule 13G/A, reflecting internal disaggregation after an internal realignment described in the filing.
The filing explains certain Vanguard subsidiaries will report separately in reliance on SEC Release No. 34-39538 (January 12, 1998). Signature block lists Ashley Grim, Head of Global Fund Administration, dated 03/26/2026.
Enovix Corp Chief Accounting Officer Kristina Truong reported routine share transfers and tax-related dispositions. On March 16, 2026 she made a bona fide gift of 6,000 shares of common stock, giving 3,000 shares to each of her two children, with no purchase or sale involved. On March 13, 2026, 970 shares were withheld at $4.94 per share to satisfy tax obligations tied to vesting restricted stock units. After these transactions she directly holds 218,356 common shares. Her holdings also include rights to additional shares through 134,843 RSUs, 2,489 vested PRSUs scheduled for release in March 2027, and 35,278 PRSUs expected to be released in tranches in April 2027 and April 2028.